We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Use the live Voya Emerging Markets High Div Eq share price chart to monitor the movements of the stock in real-time. Assess key data such as the daily change, high and low prices. A handy IHD trading ...

In my experience, the best PDF editor comes packed with a full suite of features to streamline document creation and management, from clever design tools to security redaction features. My team ...

When it comes to reviewing the best free PDF editor, I'm looking for software and apps that simplify the document design process, boast plenty of professional tools and security features, and, of ...

Genetic testing service 23andMe said on March 23 that it filed for Chapter 11 bankruptcy protection — an effort to keep the company running while reorganizing its debts. The company is ...

Goldman Sachs Dynamic Global Eq Fd earns an Average Process Pillar rating. The primary contributor to the rating is the parent firm's five-year risk-adjusted success ratio of 56%. The measure ...

March 29 (UPI) --Rapper Playboi Carti's I Am Music is the No. 1 album in the United States this week. Coming in at No. 2 on the Billboard 200 chart dated Saturday is Lady Gaga's Mayhem, followed ...

Alex Warren starts the week ahead to keep Ordinary at Number 1 for a second week. Ordinary’s success could also push Carry You Home to a brand new peak (15) inside the Top 20. A challenge could ...

Sabrina Carpenter takes Short N’ Sweet back to the summit for a fourth non-consecutive week as she brings its namesake tour to the UK. Following her performance and Global Success win at last ...

Leerink analyst Thomas Smith downgraded Equillium (EQ) to Market Perform from Outperform with a price target of $1, down from $3. The company reported “disappointing” topline results from the ...

Equillium (EQ) announced topline data from the Phase 3 EQUATOR study evaluating itolizumab in first-line treatment of patients with acute graft-versus-host disease. The study results did not ...

Covid-19 broke the charts. Decades from now, the pandemic will be visible in the historical data of nearly anything measurable today: an unmistakable spike, dip or jolt that officially began for ...